Filing Flows › Medicinova (MNOV) › Q1 2026 › vs Q4 2025
Medicinova (MNOV) Q1 2026 vs Q4 2025 (quarter over quarter)
Medicinova's revenue rose $35K (+23%) from $152K in Q4 2025 to $187K in Q1 2026.
Medicinova, Q1 2026: revenue $187K, net loss $2.6M, operating cash flow −$3.5M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $187K | $152K | $35K | +23% |
| Other income, net | $250K | $290K | −$41K | -14% |
| Net loss | $2.6M | $2.8M | −$216K | -8% |
| Costs & expenses | $3.0M | $3.2M | −$221K | -7% |
| Operating costs | $3.0M | $3.2M | −$221K | -7% |
| Research & development | $1.2M | $1.4M | −$200K | -14% |
| Sales & marketing | $170K | $147K | $23K | +16% |
| General & admin | $1.6M | $1.6M | $36K | +2% |
| Other operating costs | $63K | $143K | −$81K | -56% |
| Operating cash sources | $3.9M | $2.2M | $1.7M | +76% |
| Depreciation & amortization | $4K | $5K | −$295 | -6% |
| Share-based compensation | $408K | $181K | $227K | +126% |
| Cash used in operations | $3.5M | $2.0M | $1.5M | +72% |
| Net loss absorbed | $2.6M | $2.8M | −$216K | -8% |
| Working capital & other | $1.3M | −$600K | $1.9M | — |
Questions
How much did Medicinova's revenue grow quarter over quarter in Q1 2026?
Medicinova's revenue rose $35K (+23%) from $152K in Q4 2025 to $187K in Q1 2026.